Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute hospitalizations and death. Read More »

The case of Israel, leading the world by far in the mass vaccination contest, doesn’t leave much maneuvering room for skeptics. Since Israel launched its vast vaccination campaign in December, it has been witnessing an exponential rise in COVID-19 cases and deaths. By now, the British Mutant has become Israel’s dominant COVID strain. Israel’s health system is on the brink of collapse. Read More »

It has been recently revealed that China, the country where the first cases of coronavirus were registered back in 2019, has come up with a “more accurate” way to detect infection among its population – by effectively trying to catch the virus’ traces through the “backdoor”. Read More »

Israel has become a world leader in vaccinations for SARS-Cov-2, with about 2.5 million of its nine million citizens receiving at least one of two required vaccine jabs by late January. Last week, Covid commissioner Dr. Nachman Ash complained that the protective effect of the first dose of Pfizer/BioNTech’s preparation was lower than advertised. Read More »

Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech over the past 2 weeks may be due to a compound in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient, scientists say. A similar mRNA vaccine developed by Moderna, which was authorized for emergency use in the United States on Friday, also contains the compound, polyethylene glycol (PEG). Read More »

In the continuing story of coronavirus, this week brings two stories about limitations. The first is that production of both Pfizer and AstraZeneca vaccines in Europe is faltering, and from Monday supplies will be reduced for the next few weeks.  Read More »

The coronavirus pandemic has claimed the lives of more than 2 million people since its outbreak, prompting governments all around the world to take unprecedented measures to curb the spread of disease. However, heightened attention towards the coronavirus paved the way for resurgence of some other dangerous bacteria and fungi. Read More »

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans to focus its SARS-CoV-2/COVID-19 research strategy and production capabilities on advancing two therapeutic candidates, MK-4482 and MK-7110 Read More »

In light of a limited COVID-19 vaccine supply and rollout plans riddled with problems, US health experts are attempting to concoct additional preventative measures to combat the spread of SARS-CoV-2, the deadly coronavirus that causes COVID-19. To date, over 25 million Americans have been infected in the pandemic and over 425,000 have died. Read More »

In the United States (and other countries), historical records show that disease mortality declined nearly 90% before the introduction of the vaccine program and routine vaccination programs — as stated in the Trends in the Health of Americans report. Read More »